Realcan Pharmaceutical Group Co., Ltd. (SHE:002589)
China
· Delayed Price · Currency is CNY 2.820
-0.090 (-3.09%)
Apr 28, 2025, 2:45 PM CST
SHE:002589 Revenue
In the year 2024, Realcan Pharmaceutical Group had annual revenue of 7.97B CNY, down -0.85%. Realcan Pharmaceutical Group had revenue of 1.91B in the quarter ending December 31, 2024, a decrease of -5.68%.
Revenue
7.97B
Revenue Growth
-0.85%
P/S Ratio
0.53
Revenue / Employee
2.46M
Employees
3,239
Market Cap
4.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.97B | -68.02M | -0.85% |
| Dec 31, 2023 | 8.03B | -4.28B | -34.74% |
| Jan 1, 2023 | 12.31B | -8.75B | -41.54% |
| Jan 1, 2022 | 21.06B | -6.17B | -22.67% |
| Dec 31, 2020 | 27.23B | -8.02B | -22.76% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.77B |
| Aier Eye Hospital Group | 20.98B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.30B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |